Pex1 Protein Peroxisome Biogenesis Factor 1 is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
PEX1 (Peroxisome Biogenesis Factor 1) is a member of the AAA (ATPases Associated with diverse cellular Activities) ATPase family essential for peroxisome biogenesis <sup>[1]</sup>. [@gardner2015]
Pex1 Protein Peroxisome Biogenesis Factor 1 is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
PEX1 (Peroxisome Biogenesis Factor 1) is a member of the AAA (ATPases Associated with diverse cellular Activities) ATPase family essential for peroxisome biogenesis <sup>[1]</sup>. [@gardner2015]
Overview
PEX1 PROTEIN is a gene/protein encoding a key neuronal protein involved in synaptic function, signal transduction, and cellular homeostasis. Dysfunction of PEX1 PROTEIN is associated with neurodegenerative diseases including Alzheimer's disease, Parkinson's disease, and related disorders. [@francisco2017]
Protein Information
Structure
PEX1 contains two AAA ATPase domains (ATP-binding cassettes) and belongs to the AAA+ protein family. The protein forms a hexameric ring structure. The ATPase activity is essential for its function in receptor recycling <sup>[2]</sup>.
Key Domains
AAA ATPase domain 1 (N-terminal): First ATP-binding module
AAA ATPase domain 2 (C-terminal): Second ATP-binding module
Interaction domains: Binding sites for PEX6
Normal Function
PEX1 forms a complex with PEX6 and plays two critical roles:
Receptor Recycling: The PEX1-PEX6 complex uses ATP hydrolysis to extract the peroxisomal targeting receptor PEX5 from the peroxisomal membrane after protein import, recycling it back to the cytosol for another round of import <sup>[3]</sup>.
Peroxisome Assembly: Essential for proper peroxisome biogenesis and maintenance.
Role in Disease
Zellweger Spectrum Disorders
PEX1 is the most commonly mutated gene in Zellweger spectrum disorders. Mutations cause <sup>[4]</sup>:
Failure to import peroxisomal matrix proteins
Peroxisome deficiency
Accumulation of very-long-chain fatty acids (VLCFAs)
Defective plasmalogen synthesis
Neurodegeneration
Peroxisomal deficiency leads to:
Early-onset neurodegeneration
Developmental arrest
Severe neurological impairment
Demyelination
Therapeutic Targeting
No FDA-approved drugs target PEX1 directly. Current approaches include <sup>[5]</sup>:
Gene therapy vectors to deliver functional PEX1
Small molecule correctors to rescue mutant protein function
The study of Pex1 Protein Peroxisome Biogenesis Factor 1 has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
External Links
[PubMed](https://pubmed.ncbi.nlm.nih.gov/) - Biomedical literature
[Alzheimer's Disease Neuroimaging Initiative](https://adni.loni.usc.edu/) - Research data
[Allen Brain Atlas](https://brain-map.org/) - Brain gene expression data
References
[Steinberg SJ, et al, Peroxisome biogenesis disorders (2006)](https://doi.org/10.1016/j.bbamcr.2006.09.010)
[Gardner BM, et al, The peroxisomal AAA ATPase complex prevents the accumulation of aggregation-prone proteins (2015)](https://doi.org/10.1038/ncb3235)
[Francisco T, et al, Peroxisome biogenesis: The peroxisomal importomer (2017)](https://doi.org/10.1007/s00018-016-2442-4)
[Steinberg S, et al, Peroxisome biogenesis disorders: phenotypic spectrum, pathophysiology and therapeutic approaches (2015)](https://doi.org/10.1186/s13023-015-0238-5)
[Fujiki Y, et al, Peroxisome biogenesis disorders: from genetics to therapeutic strategies (2020)](https://doi.org/10.1002/jimd.12203)